-
1
-
-
0037129734
-
Medical Research Council Oesophageal Cancer Working Group, Surgical resection with and without chemotherapy in oesophageal cancer: A randomized controlled trial
-
Medical Research Council Oesophageal Cancer Working Group, Surgical resection with and without chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet. 2002; 359: 1727-1733.
-
(2002)
Lancet.
, vol.359
, pp. 1727-1733
-
-
-
2
-
-
0032585510
-
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
-
Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998; 339: 1979-1984.
-
(1998)
N Engl J Med.
, vol.339
, pp. 1979-1984
-
-
Kelsen, D.P.1
Ginsberg, R.2
Pajak, T.F.3
-
3
-
-
0026643829
-
Changes in serotonin metabolism in cancer patients: Its relationship to nausea and vomiting induced by chemotherapeutic drugs
-
Cubeddu LX, Hoffmann IS, Fuenmayor NT, Malave JJ,. Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs. Br J Cancer. 1992; 66: 198-203.
-
(1992)
Br J Cancer.
, vol.66
, pp. 198-203
-
-
Cubeddu, L.X.1
Hoffmann, I.S.2
Fuenmayor, N.T.3
Malave, J.J.4
-
4
-
-
0038185163
-
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists
-
Hesketh PJ, Van Belle S, Aapro M, et al. Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur J Cancer. 2003; 39: 1074-1080.
-
(2003)
Eur J Cancer.
, vol.39
, pp. 1074-1080
-
-
Hesketh, P.J.1
Van Belle, S.2
Aapro, M.3
-
5
-
-
0033540056
-
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
-
Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999; 402: 656-660.
-
(1999)
Nature.
, vol.402
, pp. 656-660
-
-
Kojima, M.1
Hosoda, H.2
Date, Y.3
-
6
-
-
0035843183
-
A role for ghrelin in the central regulation of feeding
-
Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001; 409: 194-198.
-
(2001)
Nature.
, vol.409
, pp. 194-198
-
-
Nakazato, M.1
Murakami, N.2
Date, Y.3
-
7
-
-
2942528459
-
Biological physiological, pathophysiological, and pharmacological aspects of ghrelin
-
Van der Lely AJ, Tschop M, Heiman ML, Ghigo E,. Biological physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004; 25: 426-457.
-
(2004)
Endocr Rev.
, vol.25
, pp. 426-457
-
-
Van Der Lely, A.J.1
Tschop, M.2
Heiman, M.L.3
Ghigo, E.4
-
8
-
-
46349108886
-
Efficacy of ghrelin as a therapeutic approach for age related physiological changes
-
Ariyasu H, Iwakura H, Yamada G, et al. Efficacy of ghrelin as a therapeutic approach for age related physiological changes. Endocrinology. 2008; 149: 3722-3728.
-
(2008)
Endocrinology.
, vol.149
, pp. 3722-3728
-
-
Ariyasu, H.1
Iwakura, H.2
Yamada, G.3
-
9
-
-
33750625913
-
Translational research on the clinical applications of ghrelin
-
Akamizu T, Kangawa K,. Translational research on the clinical applications of ghrelin. Endocr J. 2006; 53: 585-591.
-
(2006)
Endocr J.
, vol.53
, pp. 585-591
-
-
Akamizu, T.1
Kangawa, K.2
-
10
-
-
77949850987
-
Effects of ghrelin administration after total gastrectomy: A prospective, randomized, placebo-controlled phase II study
-
Adachi S, Takiguchi S, Okada K, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology. 2010; 138: 1312-1320.
-
(2010)
Gastroenterology.
, vol.138
, pp. 1312-1320
-
-
Adachi, S.1
Takiguchi, S.2
Okada, K.3
-
11
-
-
77953287167
-
Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction
-
Yamamoto K, Takiguchi S, Miyata H, et al. Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery. 2010; 141: 31-38.
-
(2010)
Surgery.
, vol.141
, pp. 31-38
-
-
Yamamoto, K.1
Takiguchi, S.2
Miyata, H.3
-
12
-
-
33744460486
-
Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents
-
Liu YL, Malik NM, Sanger GJ, Andrews PL,. Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents. Cancer Chemother Pharmacol. 2006; 58: 326-333.
-
(2006)
Cancer Chemother Pharmacol.
, vol.58
, pp. 326-333
-
-
Liu, Y.L.1
Malik, N.M.2
Sanger, G.J.3
Andrews, P.L.4
-
13
-
-
44649158443
-
Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism
-
Takeda H, Sadakane C, Hattori T, et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology. 2008; 134: 2004-2013.
-
(2008)
Gastroenterology.
, vol.134
, pp. 2004-2013
-
-
Takeda, H.1
Sadakane, C.2
Hattori, T.3
-
15
-
-
48849094850
-
Neoadjuvant chemotherapy (FAP) for advanced esophageal cancer
-
Shimakawa T, Naritaka Y, Asaka S, et al. Neoadjuvant chemotherapy (FAP) for advanced esophageal cancer. Anticancer Res. 2008; 28: 2321-2326.
-
(2008)
Anticancer Res.
, vol.28
, pp. 2321-2326
-
-
Shimakawa, T.1
Naritaka, Y.2
Asaka, S.3
-
16
-
-
78149411365
-
Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: A phase i dose-escalation study
-
Tanaka Y, Yoshida K, Sanada Y, et al. Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study. Cancer Chemother Pharmacol. 2010; 66: 1159-1165.
-
(2010)
Cancer Chemother Pharmacol.
, vol.66
, pp. 1159-1165
-
-
Tanaka, Y.1
Yoshida, K.2
Sanada, Y.3
-
17
-
-
12744281454
-
-
National Cancer Institute Bethesda MD: US Department of Health and Human Services, National Institutes of Health Accessed January 12, 2012
-
National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), version 4.0. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health; 2010. Available from: https://cabig-kc.nci.nih. gov/Vocab/KC/index.php/CTCAE. Accessed January 12, 2012.
-
(2010)
Common Terminology Criteria for Adverse Events (CTCAE), Version 4.0
-
-
-
18
-
-
1642406372
-
Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection
-
Igaki H, Tachimori Y, Kato H,. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg. 2004; 239: 483-490.
-
(2004)
Ann Surg.
, vol.239
, pp. 483-490
-
-
Igaki, H.1
Tachimori, Y.2
Kato, H.3
-
20
-
-
0027417437
-
The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
-
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85: 365-376.
-
(1993)
J Natl Cancer Inst.
, vol.85
, pp. 365-376
-
-
Aaronson, N.K.1
Ahmedzai, S.2
Bergman, B.3
-
21
-
-
12244299859
-
Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay
-
Akamizu T, Shinomiya T, Irako T, et al. Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab. 2005; 90: 6-9.
-
(2005)
J Clin Endocrinol Metab.
, vol.90
, pp. 6-9
-
-
Akamizu, T.1
Shinomiya, T.2
Irako, T.3
-
22
-
-
77954919923
-
Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia
-
Yakabi K, Sadakane C, Noguchi M, et al. Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology. 2010; 151: 3773-3782.
-
(2010)
Endocrinology.
, vol.151
, pp. 3773-3782
-
-
Yakabi, K.1
Sadakane, C.2
Noguchi, M.3
-
23
-
-
84865619800
-
Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients [published online ahead of print July 20, 1022]
-
Hiura Y, Takiguchi S, Yamamoto K, et al. Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients [published online ahead of print July 20, 1022]. Int J Clin Oncol. 2011.
-
(2011)
Int J Clin Oncol.
-
-
Hiura, Y.1
Takiguchi, S.2
Yamamoto, K.3
-
24
-
-
0033304680
-
Insulin-like growth factor signaling pathways in rat hepatic stellate cells: Importance for deoxyribonucleic acid synthesis and hepatocyte growth factor production
-
Skrtic S, Wallenius K, Gressner AM, Jansson AO,. Insulin-like growth factor signaling pathways in rat hepatic stellate cells: importance for deoxyribonucleic acid synthesis and hepatocyte growth factor production. Endocrinology. 1990; 140: 5729-5735.
-
(1990)
Endocrinology.
, vol.140
, pp. 5729-5735
-
-
Skrtic, S.1
Wallenius, K.2
Gressner, A.M.3
Jansson, A.O.4
-
25
-
-
0027055699
-
Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine 2F) from rat stomach fundus
-
Kursar JD, Nelson DL, Wainscott DB, Cohen ML, Baez M,. Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine 2F) from rat stomach fundus. Mol Pharmacol. 1992; 42: 549-557.
-
(1992)
Mol Pharmacol.
, vol.42
, pp. 549-557
-
-
Kursar, J.D.1
Nelson, D.L.2
Wainscott, D.B.3
Cohen, M.L.4
Baez, M.5
-
26
-
-
0028985633
-
Comparative localization of serotonin 1A, 1C and 2 receptor subtype mRNAs in rat brain
-
Wright DE, Seroogy KB, Lundgren KH, Davis BM, Jannes L,. Comparative localization of serotonin 1A, 1C and 2 receptor subtype mRNAs in rat brain. J Comp Neurol. 1995; 351: 357-373.
-
(1995)
J Comp Neurol.
, vol.351
, pp. 357-373
-
-
Wright, D.E.1
Seroogy, K.B.2
Lundgren, K.H.3
Davis, B.M.4
Jannes, L.5
-
27
-
-
31744434071
-
A negative feedback system between brain serotonin systems and plasma active ghrelin levels in mice
-
Nonogaki K, Ohashi-Nozue K, Oka Y,. A negative feedback system between brain serotonin systems and plasma active ghrelin levels in mice. Biochem Biophys Res Commun. 2006; 341: 703-707.
-
(2006)
Biochem Biophys Res Commun.
, vol.341
, pp. 703-707
-
-
Nonogaki, K.1
Ohashi-Nozue, K.2
Oka, Y.3
-
28
-
-
0027323908
-
Urinary serotonin metabolite excretion during cisplatin chemotherapy
-
Wilder-Smith OH, Borgeat A, Chappuis P, Fathi M, Forni M,. Urinary serotonin metabolite excretion during cisplatin chemotherapy. Cancer. 1993; 72: 2239-2241.
-
(1993)
Cancer.
, vol.72
, pp. 2239-2241
-
-
Wilder-Smith, O.H.1
Borgeat, A.2
Chappuis, P.3
Fathi, M.4
Forni, M.5
-
29
-
-
0035053631
-
Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis
-
Cocquyt V, Van Belle S, Reinhardt RR, et al. Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis. Eur J Cancer. 2001; 37: 835-842.
-
(2001)
Eur J Cancer.
, vol.37
, pp. 835-842
-
-
Cocquyt, V.1
Van Belle, S.2
Reinhardt, R.R.3
-
30
-
-
79955017477
-
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: Randomized, double-blind study protocol-EASE
-
Steven G, Daniel C, Anish M, et al. Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol-EASE. J Clin Oncol. 2011; 29: 1495-1501.
-
(2011)
J Clin Oncol.
, vol.29
, pp. 1495-1501
-
-
Steven, G.1
Daniel, C.2
Anish, M.3
-
31
-
-
0034771516
-
Influence of L-methionine-deprived total parenteral nutrition with 5-fluorouracil on gastric cancer and host metabolism
-
Xiao HB, Cao WX, Yin HR, Lin YZ, Ye SH,. Influence of L-methionine-deprived total parenteral nutrition with 5-fluorouracil on gastric cancer and host metabolism. World J Gastroenterol. 2001; 7: 698-701.
-
(2001)
World J Gastroenterol.
, vol.7
, pp. 698-701
-
-
Xiao, H.B.1
Cao, W.X.2
Yin, H.R.3
Lin, Y.Z.4
Ye, S.H.5
|